General MedicationsORALGeneric
DARUNAVIR
DARUNAVIR
Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview DARUNAVIR is listed in Drugs@FDA under application 207189 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DARUNAVIR Form and strength TABLET;ORAL - 400MG Sponsor CIPLA LTD Submission history Latest submission status date: 2017-03-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview DARUNAVIR is listed in Drugs@FDA under application 207189 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DARUNAVIR Form and strength TABLET;ORAL - 400MG Sponsor CIPLA LTD Submission history Latest submission status date: 2017-03-16 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.